Janet Xiao

Biography
Janet focuses on worldwide patent procurement, patent portfolio management, and strategic planning for life sciences companies. Her clients range from large multinational biopharmaceutical companies, such as Celgene and Genentech, to emerging startup companies around the world. She advises her clients on patent matters relating to various technologies, including antibody therapeutics, cell therapeutics, nanomedicine, gene therapy, drug delivery systems, diagnostics, and nutraceuticals. Janet works extensively in performing IP due diligence reviews in the contexts of VC investments, technology transactions, mergers and acquisitions, and marketing and manufacturing clearance for biopharmaceutical products. She is noted for her indepth knowledge of patent landscapes in the fields of cancer immunotherapy, gene editing, nextgeneration sequencing, liquid biopsy, antibody manufacturing, and medical devices.

---

Talk
Evolving Case Law and Practical Strategies for Immunotherapy Patents
This discussion will focus on the latest patent law developments in the field of immunotherapy including patentability issues, recent case law, and patent strategy considerations.